Medtech/healthtech

Singapore biotech startup Lucence expands across Asia, US as demand grows for preventive health tests

Ultragreen.ai's initial public offering is Singapore's biggest since 2017, excluding real estate investment trust listings.
BROKERS’ TAKE

UOBKH initiates coverage on UltraGreen.ai with ‘buy’ on optimistic growth outlook

Brain-computer interfaces represent new possibilities for restoring communication, transforming rehabilitation and enabling digital engagement for people of all abilities.

From AI nation to brainpower hub: How Singapore can fuel the brain-computer interfaces leap

Under specialised programmes, HSA experts will share insights on regulatory requirements and best practices for the medtech industry.

HSA, SMF team up to help medtech industry navigate regulation

Gurpreet Singh, a former researcher at A*Star, founded Respiree in 2019 to address "alarm fatigue" in hospitals.

Building the ‘iOS for healthcare’: Respiree’s mission to cut strain on nursing resources with smarter AI monitoring

From left: Beh Kian Teik, A*Star chief executive; Dr Tan See Leng, minister for manpower and second minister for trade and industry; Soh Leng Wan, assistant managing director (manufacturing) at Enterprise Singapore; Choo Heng Tong, executive vice-president at Economic Development Board; and Wong Anwei, executive director at Singapore Precision Engineering and Technology Association.

A*Star launches S$38 million MedTech Catapult to drive medical device commercialisation

Lucence’s founding CEO and medical director Tan Min-Han says the latest approval will ensure that more patients can benefit.

Medtech startup Lucence secures expanded US Medicare nod for cancer test

Hospitals across India are often understaffed and doctors and nurses are overworked resulting in small delays in patient care that can lead to life-threatening complications.

From AI beds to remote ICUs, startups are plugging India’s health gaps